United States · FDA National Drug Code directory
GAVILYTE-N
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43386-050_3839c7fd-e7c4-45c6-ae02-0302b40046b0
- Product NDC
- 43386-050
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- polyethylene glycol-3350, sodium chloride, potassium chloride and sodium bicarbonate
- Labeler
- Lupin Pharmaceuticals,Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20090528
- Source listing expiry
- 20261231
Source-listed ingredients
- POLYETHYLENE GLYCOL 3350 — 420 g/438.4g
- SODIUM CHLORIDE — 11.2 g/438.4g
- SODIUM BICARBONATE — 5.72 g/438.4g
- POTASSIUM CHLORIDE — 1.48 g/438.4g
These values do not establish equivalence or a dose recommendation.
Packages
- 438.4 g in 1 BOTTLE (43386-050-19) · 43386-050-19
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →